218 related articles for article (PubMed ID: 31523198)
1. Development and Validation of Tumor-educated Blood Platelets Integrin Alpha 2b (ITGA2B) RNA for Diagnosis and Prognosis of Non-small-cell Lung Cancer through RNA-seq.
Xing S; Zeng T; Xue N; He Y; Lai YZ; Li HL; Huang Q; Chen SL; Liu WL
Int J Biol Sci; 2019; 15(9):1977-1992. PubMed ID: 31523198
[No Abstract] [Full Text] [Related]
2. Tumor-educated platelet SNORD55 as a potential biomarker for the early diagnosis of non-small cell lung cancer.
Dong X; Song X; Ding S; Yu M; Shang X; Wang K; Chang M; Xie L; Song X
Thorac Cancer; 2021 Mar; 12(5):659-666. PubMed ID: 33474827
[TBL] [Abstract][Full Text] [Related]
3. TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction.
Li X; Liu L; Song X; Wang K; Niu L; Xie L; Song X
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1609-1622. PubMed ID: 33792796
[TBL] [Abstract][Full Text] [Related]
4. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.
Ma Z; Li H; Wang B; Shen Q; Cui E; Min L; Qian F; Ping J; Dai L
J Cancer Res Clin Oncol; 2013 Apr; 139(4):557-62. PubMed ID: 23224432
[TBL] [Abstract][Full Text] [Related]
5. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
6. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
7. Tumor-educated leukocytes mRNA as a diagnostic biomarker for non-small cell lung cancer.
Niu L; Guo W; Song X; Song X; Xie L
Thorac Cancer; 2021 Mar; 12(6):737-745. PubMed ID: 33474835
[TBL] [Abstract][Full Text] [Related]
8. Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.
Zhong Y; Ding X; Bian Y; Wang J; Zhou W; Wang X; Li P; Shen Y; Wang JJ; Li J; Zhang C; Wang C
Mol Oncol; 2021 Sep; 15(9):2439-2452. PubMed ID: 33340250
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
Nie W; Xu MD; Gan L; Huang H; Xiu Q; Li B
Lab Invest; 2015 Jan; 95(1):56-64. PubMed ID: 25384122
[TBL] [Abstract][Full Text] [Related]
11. Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management.
Antunes-Ferreira M; D'Ambrosi S; Arkani M; Post E; In 't Veld SGJG; Ramaker J; Zwaan K; Kucukguzel ED; Wedekind LE; Griffioen AW; Oude Egbrink M; Kuijpers MJE; van den Broek D; Noske DP; Hartemink KJ; Sabrkhany S; Bahce I; Sol N; Bogaard HJ; Koppers-Lalic D; Best MG; Wurdinger T
Sci Rep; 2023 Jun; 13(1):9359. PubMed ID: 37291189
[TBL] [Abstract][Full Text] [Related]
12. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
13. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential tumor-educated platelets RNA biomarkers in non-small-cell lung cancer by integrated bioinformatical analysis.
Xue L; Xie L; Song X; Song X
J Clin Lab Anal; 2018 Sep; 32(7):e22450. PubMed ID: 29665143
[TBL] [Abstract][Full Text] [Related]
15. The Association of Carcinoembryonic Antigen and Cytokeratin-19 Fragments 21-1 Levels with One-Year Survival of Advanced Non-Small Cell Lung Carcinoma at Cipto Mangunkusumo Hospital: A Retrospective Cohort Study.
Rumende CM; Sugianto GCK; Rinaldi I; Muhadi M
Acta Med Indones; 2020 Apr; 52(2):140-146. PubMed ID: 32778628
[TBL] [Abstract][Full Text] [Related]
16. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
17. Molecular signature comprising 11 platelet-genes enables accurate blood-based diagnosis of NSCLC.
Goswami C; Chawla S; Thakral D; Pant H; Verma P; Malik PS; Jayadeva ; Gupta R; Ahuja G; Sengupta D
BMC Genomics; 2020 Oct; 21(1):744. PubMed ID: 33287695
[TBL] [Abstract][Full Text] [Related]
18. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Fan W; Yang H; Xue H; Sun Y; Zhang J
Int J Clin Exp Pathol; 2015; 8(5):5503-8. PubMed ID: 26191257
[TBL] [Abstract][Full Text] [Related]
19. Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
Wang JL; Wu DW; Cheng ZZ; Han WZ; Xu SW; Sun NN
Asian Pac J Cancer Prev; 2014; 15(12):4865-9. PubMed ID: 24998555
[TBL] [Abstract][Full Text] [Related]
20. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
